Abstract:Abdullah Al Mamun, 1, 2 Chuxiao Shao, 1 Peiwu Geng, 1 Shuanghu Wang, 1 Jian Xiao 1– 3 1 Central Laboratory of The Lishui Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China; 2 Molecular Pharmacology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People's Republic of China; 3 Department of Wound Healing, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, People's Republic of China Correspondence: Jian Xiao, Central Laboratory of The Lishui Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China, Email Shuanghu Wang, Central Laboratory of The Lishui Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, Zhejiang, 323000, People's Republic of China, Email Pyroptosis is a pro-inflammatory form of cell death resulting from the activation of gasdermins (GSDMs) pore-forming proteins and the release of several pro-inflammatory factors. However, inflammasomes are the intracellular protein complexes that cleave gasdermin D (GSDMD), leading to the formation of robust cell membrane pores and the initiation of pyroptosis. Inflammasome activation and gasdermin-mediated membrane pore formation are the important intrinsic processes in the classical pyroptotic signaling pathway. Overactivation of the NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome triggers pyroptosis and amplifies inflammation. Current evidence suggests that the overactivation of inflammasomes and pyroptosis may further induce the progression of cancers, nerve injury, inflammatory disorders and metabolic dysfunctions. Current evidence also indicates that pyroptosis-dependent cell death accelerates the progression of diabetes and its frequent consequences including diabetic peripheral neuropathy (DPN). Pyroptosis-mediated inflammatory reaction further exacerbates DPN-mediated CNS injury. Accumulating evidence shows that several molecular signaling mechanisms trigger pyroptosis in insulin-producing cells, further leading to the development of DPN. Numerous studies have suggested that certain natural compounds or drugs may possess promising pharmacological properties by modulating inflammasomes and pyroptosis, thereby offering potential preventive and practical therapeutic approaches for the treatment and management of DPN. This review elaborates on the underlying molecular mechanisms of pyroptosis and explores possible therapeutic strategies for regulating pyroptosis-regulated cell death in the pharmacological treatment of DPN. Keywords: Diabetes mellitus, Diabetic peripheral neuropathy, Inflammation, Pyroptosis, NLRP3, Caspase-1, GSDMD, IL-1β and IL-18 Graphical The World Health Organization (WHO) states that diabetes mellitus (DM) is growing, especially in low and middle-income countries. In contrast, more DM deaths occur in those under 70 age than in high-income countries. 1,2 The seventh most common cause of mortality worldwide was DM, which affected 422 million people in 2014 and 1.6 million in 2016. Current data indicate that the prevalence of DM is anticipated to reach 642 million by 2040. 3,4 Type 2 diabetes mellitus (T2DM) is mainly characterized by increased chronic inflammation burden. 5,6 In addition, diabetic microvascular complications including diabetic peripheral neuropathy (DPN) are also characterized by a high inflammatory burden. 7,8 It is widely believed that DPN is a devastating complication of DM characterized by complex molecular pathogenesis. 9 DPN is closely related to a variety of clinical symptoms including nerve damage, paraesthesia and sensory loss and affects around 50% of adults diagnosed with diabetes. 10 However, effective therapies lack specificity and are not currently available. Thus, it is necessary to find efficient approaches against DPN based on the exact molecular mechanisms implicated in the pathogenesis. Therefore, effective therapies to alleviate DPN must be developed based on the underlying mechanisms. The pathogenesis of DPN is complex, involving chronic inflammation and dysfunction of Schwann cells as major contributing factors. 11 In addition, environmental and genetic factors including lifestyle factors such as detrimental nutrition, physical inactivity/sedentary lifestyle, obesity or overweight and alcohol and smoking consumption, have been proven to increase the risk of DPN and its complications. Numerous investigations indicate that hyperglycemia promotes AGEs and ROS overproduction, which further stimulate oxidative stress and chronic infl -Abstract Truncated-

The Stimulator of Interferon Genes Deficiency Attenuates Diabetic Myopathy Through Inhibiting NLRP3‐Mediated Pyroptosis

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation

Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors degradation and inhibiting fatty acid oxidation

Mitochondrial damage and activation of the cytosolic DNA sensor cGAS–STING pathway lead to cardiac pyroptosis and hypertrophy in diabetic cardiomyopathy mice

A Distinct Role of STING in Regulating Glucose Homeostasis Through Insulin Sensitivity and Insulin Secretion.

STING Mediates Hepatocyte Pyroptosis in Liver Fibrosis by Epigenetically Activating the NLRP3 Inflammasome.

MCC950 Ameliorates Diabetic Muscle Atrophy in Mice by Inhibition of Pyroptosis and Its Synergistic Effect with Aerobic Exercise

Pkm2-Dependent Glycolysis Promotes Skeletal Muscle Cell Pyroptosis by Activating the Nlrp3 Inflammasome in Dermatomyositis/Polymyositis

Expression of Basic Fibroblast Growth Factor, Protein Kinase C and Members of the Apoptotic Pathway in Skeletal Muscle of Streptozotocin-Induced Diabetic Rats

Ablation of NLRP3 inflammasome attenuates muscle atrophy via inhibiting pyroptosis, proteolysis and apoptosis following denervation

STING Deletion Alleviates Podocyte Injury Through Suppressing Inflammation by Targeting NLRP3 in Diabetic Kidney Disease

Inhibition of Stimulator of Interferon Genes Protects Against Myocardial Ischemia-Reperfusion Injury in Diabetic Mice

Deficiency of muscle-generated brain-derived neurotrophic factor causes inflammatory myopathy through reactive oxygen species-mediated necroptosis and pyroptosis

STING Drives Pyroptosis and Exacerbates Intestinal Ischemia-Reperfusion Injury

STING Activation Promotes Inflammatory Response and Delays Skin Wound Healing in Diabetic Mice.

Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury

Pyroptosis in Diabetic Peripheral Neuropathy and its Therapeutic Regulation

STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke

Deletion of Stimulator of Interferons Genes Aggravated Cardiac Dysfunction in Physiological Aged Mice

STING-IRF3 Contributes to Lipopolysaccharide-Induced Cardiac Dysfunction, Inflammation, Apoptosis and Pyroptosis by Activating NLRP3

Pulsed electromagnetic fields alleviate streptozotocin‑induced diabetic muscle atrophy